Form 8-K - Current report:
SEC Accession No. 0001079973-25-001106
Filing Date
2025-07-03
Accepted
2025-07-03 16:01:55
Documents
13
Period of Report
2025-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 27682
2 FORM OF PROMISSORY NOTE ex4x1.htm EX-4.1 37356
  Complete submission text file 0001079973-25-001106.txt   236789

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE scpx-20250630.xsd EX-101.SCH 3099
4 XBRL LABEL FILE scpx-20250630_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE scpx-20250630_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 3359
Mailing Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 251105505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)